BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20971173)

  • 1. Modeling of small-molecule release from crosslinked hydrogel microspheres: effect of crosslinking and enzymatic degradation of hydrogel matrix.
    Cheng F; Choy YB; Choi H; Kim KK
    Int J Pharm; 2011 Jan; 403(1-2):90-5. PubMed ID: 20971173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monodisperse gelatin microspheres as a drug delivery vehicle: release profile and effect of crosslinking density.
    Choy YB; Cheng F; Choi H; Kim KK
    Macromol Biosci; 2008 Aug; 8(8):758-65. PubMed ID: 18446808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM; Takezoe K; Yamaura K
    Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of drugs from multi-component biomaterials.
    Zalfen AM; Nizet D; Jérôme C; Jérôme R; Frankenne F; Foidart JM; Maquet V; Lecomte F; Hubert P; Evrard B
    Acta Biomater; 2008 Nov; 4(6):1788-96. PubMed ID: 18583206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
    Dinarvand R; Mahmoodi S; Farboud E; Salehi M; Atyabi F
    Acta Pharm; 2005 Mar; 55(1):57-67. PubMed ID: 15907224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel enzymatic technique for limiting drug mobility in a hydrogel matrix.
    Burke MD; Park JO; Srinivasarao M; Khan SA
    J Control Release; 2005 May; 104(1):141-53. PubMed ID: 15866341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and characterization of tramadol-loaded IPN microgels of alginate and gelatin: Optimization using response surface methodology.
    Kumar P; Singh I
    Acta Pharm; 2010 Sep; 60(3):295-310. PubMed ID: 21134864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in vitro characterization of spray dried microspheres of amoxicillin.
    Raval JA; Patel JK; Patel MM
    Acta Pharm; 2010 Dec; 60(4):455-65. PubMed ID: 21169137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY; Gu YH; Su ZG; Ma GH
    Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent and ionic co-cross-linking--an original way to prepare chitosan-gelatin hydrogels for biomedical applications.
    Jătariu Cadinoiu AN; Popa M; Curteanu S; Peptu CA
    J Biomed Mater Res A; 2011 Sep; 98(3):342-50. PubMed ID: 21626665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.
    Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M
    Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and in vitro evaluation of gelatin microspheres containing an antitumour tetra-amidine.
    Nastruzzi C; Pastesini C; Cortesi R; Esposito E; Gambari R; Menegatti E
    J Microencapsul; 1994; 11(3):249-60. PubMed ID: 8064549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
    Gu YH; Wang LY; Tan TW; Ma GH
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs.
    Constantin M; Fundueanu G; Bortolotti F; Cortesi R; Ascenzi P; Menegatti E
    Int J Pharm; 2004 Nov; 285(1-2):87-96. PubMed ID: 15488682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing.
    Hori K; Sotozono C; Hamuro J; Yamasaki K; Kimura Y; Ozeki M; Tabata Y; Kinoshita S
    J Control Release; 2007 Apr; 118(2):169-76. PubMed ID: 17289206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres.
    Narayani R; Rao KP
    J Microencapsul; 1994; 11(1):69-77. PubMed ID: 8138876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
    Lee F; Chung JE; Kurisawa M
    J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds.
    Leach JB; Schmidt CE
    Biomaterials; 2005 Jan; 26(2):125-35. PubMed ID: 15207459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.